tiprankstipranks
pc:rapaf

Rapafusyn Pharmaceuticals

Rapafusyn Pharmaceuticals is a pioneering company in the discovery and development of non-degrading molecular glue therapeutics. Utilizing its proprietary RapaGlue™ platform, Rapafusyn focuses on creating innovative macrocyclic molecules to target challenging and previously undruggable disease targets. The company leverages advanced machine learning and AI methods for target selection and drug candidate optimization, addressing high unmet medical needs in oncology, immunology, renal, and pain diseases. Rapafusyn's approach enhances drug discovery by forming neo-protein-protein interactions, offering promising therapeutic potential.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$44M
Total Amount Raised$44M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$44M
Latest Funding Amount$44M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 04, 2025
Series A
$44.00M

Investors

Investor Name
Funding Round

Related News and Analysis